Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if dovitinib is an effective treatment for patients
with advanced lung cancer or advanced colorectal cancer (CRC) who have progressed on
anti-vascular endothelial growth factor (VEGF) treatment.